Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
- PMID: 20064223
- PMCID: PMC2820043
- DOI: 10.1186/1475-2875-9-9
Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
Abstract
Background: Intermittent preventive treatment in infants (IPTi) with sulphadoxine-pyrimethamine (SP) given during routine vaccinations is efficacious in preventing malaria disease and shows no interaction with the vaccines. However, there is a fear that IPTi may result in a rapid increase of parasite resistance to SP.
Methods: To evaluate the impact of IPTi on SP-resistance point mutations, the 22 health sub-districts in the district of Kolokani, Mali, were randomized in a 1:1 ratio and starting in December 2006, IPTi with SP was implemented in 11 health sub-districts (intervention zone), while the other 11 health sub-districts served as the control (non-intervention zone). Blood smears and blood dots on filter paper were obtained from children aged 0-5 years, randomly selected in each of heath sub-districts during two cross-sectional surveys. The first survey was conducted in May 2007 before the start of the transmission season to collect baseline prevalence of the molecular markers of resistance to SP and the second in December 2007 after the end of the transmission season and one year after implementation of IPTi. A total of 427 and 923 randomly selected blood samples from the first and second surveys respectively were analysed by PCR for dhfr and dhps mutations.
Results: Each of the three dhfr mutations at codons 51, 59 and 108 was present in 35% and 57% of the samples during the two surveys with no significant differences between the two zones. Dhps mutations at codons 437 and 540 were present respectively in about 20% and 1% of the children during the two surveys in both zones at similar proportion. The prevalence of quadruple mutants (triple dhfr-mutants + dhps-437G) associated with in-vivo resistance to SP in Mali after one year implementation of IPTi was also similar between the two zones (11.6% versus 11.2%, p = 0.90) and to those obtained at baseline survey (10.3% versus 8.1%).
Conclusion: This study shows no increase in the frequency of molecular markers of SP resistance in areas where IPTi with SP was implemented for one year.
Similar articles
-
Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.BMC Public Health. 2011 Jul 18;11:573. doi: 10.1186/1471-2458-11-573. BMC Public Health. 2011. PMID: 21767403 Free PMC article. Clinical Trial.
-
Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.Parasitology. 2011 Oct;138(12):1469-79. doi: 10.1017/S0031182011000746. Epub 2011 Aug 11. Parasitology. 2011. PMID: 21835078 Free PMC article. Review.
-
Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.C R Biol. 2013 May-Jun;336(5-6):295-300. doi: 10.1016/j.crvi.2013.04.016. Epub 2013 Jul 18. C R Biol. 2013. PMID: 23916206
-
Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.Malar J. 2022 Feb 8;21(1):39. doi: 10.1186/s12936-022-04059-z. Malar J. 2022. PMID: 35135546 Free PMC article.
-
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.Lancet. 2009 Oct 31;374(9700):1533-42. doi: 10.1016/S0140-6736(09)61258-7. Epub 2009 Sep 16. Lancet. 2009. PMID: 19765816 Review.
Cited by
-
Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.BMC Public Health. 2011 Jul 18;11:573. doi: 10.1186/1471-2458-11-573. BMC Public Health. 2011. PMID: 21767403 Free PMC article. Clinical Trial.
-
Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali.Parasite Epidemiol Control. 2022 Jun 22;18:e00258. doi: 10.1016/j.parepi.2022.e00258. eCollection 2022 Aug. Parasite Epidemiol Control. 2022. PMID: 35789762 Free PMC article. Review.
-
Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.Parasitology. 2011 Oct;138(12):1469-79. doi: 10.1017/S0031182011000746. Epub 2011 Aug 11. Parasitology. 2011. PMID: 21835078 Free PMC article. Review.
-
The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia.Malar J. 2012 Aug 1;11:251. doi: 10.1186/1475-2875-11-251. Malar J. 2012. PMID: 22853645 Free PMC article.
-
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.Malar J. 2011 Jul 19;10:196. doi: 10.1186/1475-2875-10-196. Malar J. 2011. PMID: 21767415 Free PMC article.
References
-
- WHO, World Malaria Report. 2008. http://www.who.int/malaria/wmr2008/malaria2008.pdf
-
- Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M, Mshinda H, Alonso P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet. 2001;357:1471–1477. doi: 10.1016/S0140-6736(00)04643-2. - DOI - PubMed
-
- Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, Jaffar S, Baiden R, Hodgson A, Binka F, Greenwood B. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ. 2005;331:727–733. doi: 10.1136/bmj.331.7519.727. - DOI - PMC - PubMed
-
- Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis. 2006;194:276–285. doi: 10.1086/505431. - DOI - PubMed
-
- Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA, Abruquah HH, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer CG, Adjei O, May J. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clin Infect Dis. 2007;45:6–25. doi: 10.1086/518575. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical